Cutaneous manifestations of category A bioweapons.
Aquino LL, Wu JJ.
J Am Acad Dermatol. 2011 Dec;65(6):1213.e1-1213.e15. doi: 10.1016/j.jaad.2010.08.040. Epub 2011 Jul 20.
A Case of Cutaneous Plague.
De Rozario CF.
Ind Med Gaz. 1933 Jul;68(7):396.
On Shakespeare and cutaneous diseases.
Xu J.
Clin Dermatol. 2021 Jul-Aug;39(4):714-717. doi: 10.1016/j.clindermatol.2021.05.018. Epub 2021 May 19.
Systemic diseases with cutaneous manifestations.
Merchant SR, Taboada J.
Vet Clin North Am Small Anim Pract. 1995 Jul;25(4):945-59. doi: 10.1016/s0195-5616(95)50136-6.
Orf Viral Infection.
Efridi W, Jain H, Sathe NC, Ahmed K.
2023 Nov 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Anthrax.
Wenner KA, Kenner JR.
Dermatol Clin. 2004 Jul;22(3):247-56, v. doi: 10.1016/j.det.2004.03.001.
Periorbital cellulitis due to cutaneous anthrax.
Gilliland G, Starks V, Vrcek I, Gilliland C.
Int Ophthalmol. 2015 Dec;35(6):843-5. doi: 10.1007/s10792-015-0057-7. Epub 2015 Mar 13.
Boils-A Modern Take on the Plague of Egypt.
Rodriguez V, Maranda EL, Cortizo J, Augustynowicz A, Crow LD, Jimenez JJ.
JAMA Dermatol. 2016 Sep 1;152(9):991. doi: 10.1001/jamadermatol.2016.0245.
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague.
Shattock RJ, Andrianaivoarimanana V, McKay PF, Randriantseheno LN, Murugaiah V, Samnuan K, Rogers P, Tregoning JS, Rajerison M, Moore KM, Laws TR, Williamson ED.
Front Microbiol. 2023 Nov 2;14:1247041. doi: 10.3389/fmicb.2023.1247041. eCollection 2023.
Dual route vaccination for plague with emergency use applications.
Moore BD, New RRC, Butcher W, Mahood R, Steward J, Bayliss M, MacLeod C, Bogus M, Williamson ED.
Vaccine. 2018 Aug 16;36(34):5210-5217. doi: 10.1016/j.vaccine.2018.06.039. Epub 2018 Jul 14.
